Want to join the conversation?
$ENDP's revenue from U.S. Generic Pharmaceuticals for 4Q15 jumped 81% to $609MM from last year, on growth from addition of sales from acquisition of Par Pharmaceutical, as well as underlying growth of certain products. Revenue from International Pharmaceuticals rose 7% to $85MM on sales growth in Mexico.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?